Fig. 2From: Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s diseaseTMSE decline-free survival between patients stratified by different age groups. Patients who started ChEI therapy at the age of 60 years or younger had a more rapid TMSE decline as compared to other age groups TMSE Taiwanese Mini-Mental State Examination, ChEI cholinesterase inhibitorBack to article page